Finance

Lists
Why is IMA down 5,91%?
Dive Deeper
IMA:NASDAQ
ImageneBio Inc
3,50 US$
-5,91%
(-0,22) 1D
12 ნოე, 13:43:38 GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for IMA...
Open
3,83 US$
High
3,83 US$
Low
3,50 US$
Mkt. cap
43,60 მლნ.
Avg. vol.
12,44 ათ.
Volume
5,55 ათ.
52-wk high
8,70 US$
52-wk low
3,50 US$
EPS
-5,44 US$
Beta
0,83
Shares outstanding
11,35 მლნ.
No. of employees
18
Open
3,83 US$
High
3,83 US$
Low
3,50 US$
Mkt. cap
43,60 მლნ.
Avg. vol.
12,44 ათ.
Volume
5,55 ათ.
52-wk high
8,70 US$
52-wk low
3,50 US$
EPS
-5,44 US$
Beta
0,83
Shares outstanding
11,35 მლნ.
No. of employees
18
News stories
From web sources and news partners
Yahoo! Finance Canada
Yahoo! Finance Canada
·
2 დღის წინ
ImageneBio Reports Third Quarter 2026 Financial Results
About ImageneBio Inc
CEO-
Employees18
Founded-
Headquarters-
SectorHealth Care
Industry-
Analyst ratings
Based on 1 analyst giving stock ratings to IMA in the past 3 months
Buy
Buy
1
Hold
0
Sell
0
12-month forecast
Based on 1 Wall Street analyst offering 12-month price targets for IMA in the last 3 months
Highest
Current 3,50 US$
28,00 US$ (+699,98%)
Average
28,00 US$ (+699,98%)
Lowest
28,00 US$ (+699,98%)
Analyst
Recommendation
Action
Price target
Projected
Date
Arthur He CFA
H.C. Wainwright
Buy
Maintained
28,00 US$
+700%
10/01/2026
Martin Fan
Wedbush
Sell
Maintained
2,00 US$
-42,9%
08/06/2026
Matt Phipps
William Blair
Buy
Maintained
-
-
08/05/2026
David Risinger
Leerink Partners
Buy
Maintained
24,00 US$
+585,7%
05/08/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
15,56 მლნ.
3,27 მლნ.
5,96 მლნ.
6,67 მლნ.
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
11,04 მლნ.
5,23 მლნ.
6,12 მლნ.
5,12 მლნ.
Operating expense
26,59 მლნ.
8,50 მლნ.
12,08 მლნ.
11,78 მლნ.
Total operating expenses
26,59 მლნ.
8,50 მლნ.
12,08 მლნ.
11,78 მლნ.
Operating income
-26,59 მლნ.
-8,50 მლნ.
-12,08 მლნ.
-11,78 მლნ.
Other non operating income
1,84 მლნ.
-1,12 მლნ.
341,00 ათ.
374,00 ათ.
EBT including unusual items
-24,85 მლნ.
-7,18 მლნ.
-10,61 მლნ.
-10,16 მლნ.
EBT excluding unusual items
-24,85 მლნ.
-7,18 მლნ.
-10,62 მლნ.
-10,16 მლნ.
Income tax expense
-74,00 ათ.
-276,00 ათ.
10,00 ათ.
16,00 ათ.
Effective tax rate
0,30%
3,84%
-0,09%
-0,16%
Other operating expenses
-
-
-
-
Net income
-24,78 მლნ.
-6,91 მლნ.
-10,62 მლნ.
-10,18 მლნ.
Net profit margin
-
-
-
-
Earnings per share
-2,91
-
-0,95
-0,63
Interest and investment income
-
2,44 მლნ.
1,12 მლნ.
1,25 მლნ.
Interest expense
-96,00 ათ.
-
-
-
Net interest expenses
-96,00 ათ.
2,44 მლნ.
1,12 მლნ.
1,25 მლნ.
Depreciation and amortization charges
-
-
-
-
EBITDA
-26,59 მლნ.
-8,11 მლნ.
-11,98 მლნ.
-11,68 მლნ.
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
Google აპები